Quantbot Technologies’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Sell
30,323
-3,189
-10% -$28.6K 0.01% 1068
2025
Q4
$271K Buy
+33,512
New +$366K 0.01% 1144
2024
Q2
Sell
-14,719
Closed -$276K 1485
2024
Q1
$276K Sell
14,719
-7,214
-33% -$144K 0.02% 918
2023
Q4
$497K Buy
21,933
+2,801
+15% +$60.7K 0.03% 736
2023
Q3
$474K Buy
19,132
+17,167
+874% +$432K 0.03% 652
2023
Q2
$55.2K Sell
1,965
-56,967
-97% -$1.41M ﹤0.01% 1300
2023
Q1
$1.32M Buy
58,932
+51,365
+679% +$1.35M 0.09% 325
2022
Q4
$201K Sell
7,567
-4,836
-39% -$158K 0.01% 899
2022
Q3
$351K Sell
12,403
-3,437
-22% -$88.4K 0.03% 698
2022
Q2
$329K Buy
15,840
+3,381
+27% +$63.4K 0.03% 743
2022
Q1
$269K Buy
+12,459
New +$270K 0.02% 767

Other funds holding CCRN

Quantbot Technologies's CCRN Position: Q1 2026 in Review

Quantbot Technologies reduced its Cross Country Healthcare (CCRN) stake by 9.5% in Q1 2026, selling an estimated $28.6K and leaving 30,323 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #1068.

Quantbot Technologies first reported a position in CCRN in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.32M in Q1 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Quantbot Technologies held 30,323 shares of Cross Country Healthcare worth $285K as of Q1 2026.
  • Quantbot Technologies sold 3,189 Cross Country Healthcare shares in Q1 2026, an estimated $28.6K.
  • Cross Country Healthcare made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1068 holding.
  • Quantbot Technologies first reported a position in Cross Country Healthcare in Q1 2022 and has held it in 11 quarters since.
  • Quantbot Technologies's Cross Country Healthcare position peaked at $1.32M in Q1 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.